Amundi Russell 1000 Growth UCITS ETF Acc is a equity ETF from Amundi tracking the Russell 1000 Growth index through physical replication. Domiciled in Ireland and launched in 2024, the fund manages about 598 M € and charges a TER of 0.19% — 19 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Amundi Russell 1000 Growth UCITS ETF Acc competes with 1 other products on the same index (Russell 1000 Growth): it ranks 2nd by fund size and 2nd by ongoing cost, with a TER of 0.19% against a group median of 0.19%. It has been listed since 2024, 2 years of track record.
On a €10,000 investment the TER costs 19 € a year. The cheapest of the group is iShares Russell 1000 Growth UCITS ETF USD Acc at 0.18%, or 18 € on the same amount: a difference of 1 € every year, roughly 10 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 54.6% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 13.9% |
| Apple Inc. | 6.7% |
| Alphabet Inc Class A | 6.2% |
| Broadcom Inc | 5.2% |
| Alphabet Inc Class C | 5.0% |
| Microsoft Corporation | 4.1% |
| Micron Technology Inc | 3.9% |
| Tesla Inc | 3.7% |
| Meta Platforms Inc. | 3.0% |
| Eli Lilly and Company | 2.9% |
| XETRA | MWOT | USD |
| XETRA | MWOW | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.